IBB vs VIG
iShares Biotechnology ETF vs Vanguard Dividend Appreciation ETF
- • VIG has the lower expense ratio at 0.04% vs 0.44% for IBB.
- • VIG pays a higher dividend yield (1.51%).
Side-by-side metrics
| Metric | IBB | VIG |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.44% | 0.04% |
Dividend yield Trailing 12-month yield. | 0.23% | 1.51% |
AUM Assets under management — bigger funds are typically more liquid. | $7.95B | $124.65B |
YTD return | 3.10% | 4.98% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.74 | 0.79 |
P/E ratio | 23.72 | 26.45 |
Last price | $170.10 | $228.11 |
Inception | — | — |
Issuer | iShares | Vanguard |
IBB top holdings
| AMGN | Amgen Inc | 7.37% |
| GILD | Gilead Sciences Inc | 7.32% |
| VRTX | Vertex Pharmaceuticals Inc | 7.21% |
| REGN | Regeneron Pharmaceuticals Inc | 6.55% |
| ALNY | Alnylam Pharmaceuticals Inc | 3.71% |
| ARGX | argenx SE ADR | 3.33% |
| INSM | Insmed Inc | 2.70% |
| BIIB | Biogen Inc | 2.67% |
| NTRA | Natera Inc | 2.40% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.27% |
VIG top holdings
| AVGO | Broadcom Inc | 4.07% |
| AAPL | Apple Inc | 4.03% |
| MSFT | Microsoft Corp | 3.81% |
| JPM | JPMorgan Chase & Co | 3.53% |
| LLY | Eli Lilly and Co | 3.48% |
| XOM | Exxon Mobil Corp | 3.38% |
| JNJ | Johnson & Johnson | 2.81% |
| WMT | Walmart Inc | 2.60% |
| V | Visa Inc Class A | 2.26% |
| COST | Costco Wholesale Corp | 2.11% |
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $7.9B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.23%. Its largest holding is Amgen Inc (AMGN), which represents 7.4% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.
About VIG
VIG (Vanguard Dividend Appreciation ETF) is US companies with a record of growing dividends. Managed by Vanguard, the fund carries $124.6B in assets under management, an expense ratio of 0.04%, a dividend yield of 1.51%. Its largest holding is Broadcom Inc (AVGO), which represents 4.1% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 5.0%.